JP2002281993A - Method for producing shikimic acid - Google Patents

Method for producing shikimic acid

Info

Publication number
JP2002281993A
JP2002281993A JP2001089091A JP2001089091A JP2002281993A JP 2002281993 A JP2002281993 A JP 2002281993A JP 2001089091 A JP2001089091 A JP 2001089091A JP 2001089091 A JP2001089091 A JP 2001089091A JP 2002281993 A JP2002281993 A JP 2002281993A
Authority
JP
Japan
Prior art keywords
acid
shikimic acid
medium
microorganism
shikimic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001089091A
Other languages
Japanese (ja)
Inventor
Reiko Miyata
令子 宮田
Yuji Echigo
裕司 越後
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2001089091A priority Critical patent/JP2002281993A/en
Publication of JP2002281993A publication Critical patent/JP2002281993A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To economically produce shikimic acid by using a microorganism. SOLUTION: The objective shikimic acid is produced by utilizing a microorganism that belongs to the genus Citrobacter and secrets the shikimic acid extracellularly.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】シキミ酸は、不斉炭素を3個
持つ光学活性体であり、医薬原料などに利用される。
BACKGROUND OF THE INVENTION Shikimic acid is an optically active substance having three asymmetric carbon atoms, and is used as a raw material for pharmaceuticals.

【0002】[0002]

【従来の技術】従来シキミ酸は、植物からの抽出、キナ
酸あるいは糖類を原料とした合成(ケミカル レビュー
(Chemical Review) 65 435(1965))、大腸菌を用いて
発酵で生成させる方法(ジャーナル バイオロジカル
ケミストリー(Journal Biological Chemistry) 191 3
15(1951))、組換え大腸菌による発酵で生成させる方法
(ジャーナル オブ アメリカン ケミカル ソサイエ
テイ(Journal of American Chemical Society)121 160
3 (1999))などが知られている。また、シトロバクター
属に属する微生物によるシキミ酸産生として特開平20
00−78967号公報があげられる。
2. Description of the Related Art Conventionally, shikimic acid is extracted from plants, synthesized from quinic acid or saccharides (Chemical Review 65 435 (1965)), and produced by fermentation using Escherichia coli (Journal Biotechnology). logical
Chemistry (Journal Biological Chemistry) 191 3
15 (1951)), a method of producing by fermentation with recombinant Escherichia coli (Journal of American Chemical Society) 121 160
3 (1999)). Further, production of shikimic acid by a microorganism belonging to the genus Citrobacter is disclosed in
No. 00-78967.

【0003】[0003]

【発明が解決しようとする課題】植物からの抽出法は、
植物中のシキミ酸含量が低く、精製が困難である。キナ
酸あるいは糖類を原料とした合成法は、原料価格が高い
こと、さらに合成ステップも長い問題がある。さらに発
酵による生産法は、副生物が多いなどの問題がある。
The method of extracting from plants is as follows.
The shikimic acid content in the plant is low and purification is difficult. The synthesis method using quinic acid or a saccharide as a raw material has problems that the raw material price is high and the synthesis step is long. Furthermore, the production method by fermentation has a problem that there are many by-products.

【0004】また、シトロバクター属に属する微生物に
よる発酵法においても、シキミ酸の蓄積濃度が十分でな
いなどの問題点があった。
[0004] In addition, the fermentation method using microorganisms belonging to the genus Citrobacter also has a problem that the accumulated concentration of shikimic acid is not sufficient.

【0005】[0005]

【課題を解決するための手段】本発明者らは、上記問題
点を解決するため、大腸菌以外にシキミ酸を生産する潜
在能力を持つ微生物を探索し、シキミ酸を菌体外に分泌
する微生物を広く検討した結果、特定の性質を有する微
生物の変異株がシキミ酸を菌体外に分泌することを見い
出した。通常の発酵法、すなわち、炭素源および窒素源
などを添加し、微生物が増殖しながら、生産物を生成す
る方法で、シキミ酸が菌体外に生成蓄積されることは当
然であるが、さらに通常の発酵法とは異なり、培養によ
って得られた菌体または培養物、もしくはそれらの処理
物を用い、事実上微生物の増殖が停止し、酵素反応のみ
が行われる条件で、炭素源からシキミ酸を生成し、菌体
外に分泌することも本発明に含まれる。
Means for Solving the Problems In order to solve the above problems, the present inventors have searched for microorganisms other than Escherichia coli that have the potential to produce shikimic acid, and discovered microorganisms that secrete shikimic acid outside the cells. As a result of extensive studies, it was found that a mutant strain of a microorganism having specific properties secreted shikimic acid outside the cells. In a normal fermentation method, that is, a method of adding a carbon source and a nitrogen source and the like to produce a product while the microorganisms grow, it is natural that shikimic acid is produced and accumulated outside the cells, Unlike ordinary fermentation methods, using bacterial cells or cultures obtained by culturing, or their processed products, the growth of microorganisms is effectively stopped, and shikimic acid is removed from a carbon source under conditions where only enzymatic reactions are performed. It is also included in the present invention to produce and secrete extracellularly.

【0006】なお菌体外にシキミ酸を分泌するというの
は、培養液の培地中にシキミ酸を生成すること、すなわ
ち、培養液から遠心分離あるいは濾過などの方法で微生
物を除いた培養上清中にシキミ酸が生成蓄積されること
を示す。
[0006] The secretion of shikimic acid outside the cells means that shikimic acid is produced in the medium of the culture solution, that is, the culture supernatant obtained by removing microorganisms from the culture solution by centrifugation or filtration. This indicates that shikimic acid is produced and accumulated therein.

【0007】シキミ酸の生産効率を向上させるために適
した微生物の変異株は、p-ヒドロキシ安息香酸アナログ
に耐性な変異株であることを見出し、本発明の完成に至
った。すなわち、本発明は、シキミ酸を菌体外に分泌す
る性質を有し、かつp-ヒドロキシ安息香酸アナログに耐
性な性質を持つ微生物を用いたシキミ酸の製造方法であ
る。
The present inventors have found that a mutant strain of a microorganism suitable for improving the efficiency of shikimic acid production is a mutant strain resistant to a p-hydroxybenzoic acid analog, and have completed the present invention. That is, the present invention is a method for producing shikimic acid using a microorganism having a property of secreting shikimic acid outside the cells and having a property of being resistant to a p-hydroxybenzoic acid analog.

【0008】[0008]

【発明の実施の形態】本発明に使用する微生物は、シキ
ミ酸を菌体外に分泌する性質を有し、かつp-ヒドロキシ
安息香酸アナログに耐性な性質を有するものであればい
ずれでもよいが、シキミ酸が芳香族アミノ酸生合成系の
代謝中間体であるため、芳香族アミノ酸の生合成が強い
ものが望ましい。好ましくは、シトロバクター属に属す
る微生物、さらに好ましくは、シトロバクター・フロイ
ンディである。本発明の親株として用いられるシキミ酸
分泌株の代表的なものとして、シトロバクター・フロイ
ンディ 4AA-12(FERM BP-6722)株があげられる。この
変異株はシトロバクター・フロインディ IFO13545株か
ら5-フルオロトリプトファン耐性およびo-フルオロフェ
ニルアラニン耐性の性質を獲得して芳香族アミノ酸生産
菌となったOFPR36-158株を親株として、通常の変異処理
方法によって得られたもので、シキミ酸分泌性の変異株
である。
BEST MODE FOR CARRYING OUT THE INVENTION The microorganism used in the present invention may be any microorganism as long as it has a property of secreting shikimic acid outside the cells and a property of being resistant to a p-hydroxybenzoic acid analog. Since shikimic acid is a metabolic intermediate of the aromatic amino acid biosynthesis system, it is desirable that the aromatic amino acid biosynthesis is strong. Preferably, it is a microorganism belonging to the genus Citrobacter, more preferably, Citrobacter freundi. A representative shikimate secreting strain used as a parent strain of the present invention is Citrobacter freundii 4AA-12 (FERM BP-6722). This mutant strain obtained 5-fluorotryptophan resistance and o-fluorophenylalanine resistance from the Citrobacter Freundi IFO13545 strain and became an aromatic amino acid-producing strain, OFPR36-158 strain, as a parent strain. This is a shikimate-secreting mutant.

【0009】変異株の誘導は親株を紫外線照射するか、
あるいは変異誘発剤(例えばN−メチル−N’−ニトロ
−N−ニトロソグアニジン、エチルメタンスルホン酸
等)で処理した後、公知の方法でシキミ酸分泌性の変異
株を得ることができる。例えば親株を変異誘発処理の
後、天然培地などの良好に生育する寒天培地に生育さ
せ、生育したコロニーを、あらかじめ芳香族アミノ酸4
種類(L-チロシン、L-フェニルアラニン、L-トリプトフ
ァン)およびp−アミノ安息香酸を含んだ最小培地およ
びこれらのアミノ酸とビタミンを含まない最小培地にレ
プリカし、これらのアミノ酸およびビタミンを含んだ最
小培地上でのみ生育したコロニーを取得する。
[0009] The induction of the mutant strain is carried out by irradiating the parent strain with ultraviolet light,
Alternatively, after treatment with a mutagen (eg, N-methyl-N'-nitro-N-nitrosoguanidine, ethyl methanesulfonic acid, etc.), a shikimate-secreting mutant can be obtained by a known method. For example, the parent strain is grown on a well-growing agar medium such as a natural medium after the mutagenesis treatment.
Minimal medium containing these amino acids and vitamins, replicating to a minimal medium containing the species (L-tyrosine, L-phenylalanine, L-tryptophan) and p-aminobenzoic acid and a minimal medium containing these amino acids and vitamins Obtain colonies that grew only on top.

【0010】本発明に使用するp-ヒドロキシ安息香酸ア
ナログはp-ヒドロキシ安息香酸の構造類似体で、微生物
の生育を阻害しする化合物である。このような性質があ
ればどのような物でもよいが、その例としては4-ヒド
ロキシ-3-メトキシ安息香酸、m-ヒドロキシ安息香酸、
o-ヒドロキシ安息香酸などがあげられる。
The p-hydroxybenzoic acid analog used in the present invention is a structural analog of p-hydroxybenzoic acid, which is a compound that inhibits the growth of microorganisms. Any substance having such properties may be used, but examples thereof include 4-hydroxy-3-methoxybenzoic acid, m-hydroxybenzoic acid,
o-Hydroxybenzoic acid and the like.

【0011】p-ヒドロキシ安息香酸アナログ耐性株は、
その化合物の培地への添加により微生物の親株の生育が
阻害される濃度で、生育できる変異株のことを示す。
The p-hydroxybenzoic acid analog resistant strain is
A mutant strain capable of growing at a concentration at which the growth of a parent strain of a microorganism is inhibited by the addition of the compound to a medium is indicated.

【0012】本発明で用いられるp-ヒドロキシ安息香酸
アナログに耐性なシキミ酸分泌株の代表的なものとし
て、シトロバクター・フロインディ U-5(FERM P−
18267)株があげられる。この変異株はシトロバク
ター・フロインディ4AA-12(FERM BP-6722)を親株とし
て得られた変異株である。
A representative shikimate secreting strain resistant to the p-hydroxybenzoic acid analog used in the present invention is Citrobacter Freundi U-5 (FERM P-
18267) strains. This mutant is a mutant obtained using Citrobacter Freundi 4AA-12 (FERM BP-6722) as a parent strain.

【0013】変異株の誘導は親株を紫外線照射するか、
あるいは変異誘発剤(例えばN−メチル−N’−ニトロ
−N−ニトロソグアニジン、エチルメタンスルホン酸
等)で処理した後、親株が生育できない濃度のp-ヒドロ
キシ安息香酸アナログを添加した培地で生育してきた微
生物を得ればよい。
The induction of the mutant strain is carried out by irradiating the parent strain with ultraviolet rays,
Alternatively, after treatment with a mutagenic agent (for example, N-methyl-N'-nitro-N-nitrosoguanidine, ethyl methanesulfonic acid, etc.), the cells are grown in a medium to which a p-hydroxybenzoic acid analog at a concentration at which the parent strain cannot grow is added. Microorganisms can be obtained.

【0014】本発明の発酵法における培養方法について
説明する。シキミ酸生産用の培地は、炭素源、窒素源、
無機イオンおよび必要に応じてその他の有機微量成分を
含有する通常の培地が使用できる。
The culture method in the fermentation method of the present invention will be described. The medium for shikimic acid production includes a carbon source, a nitrogen source,
A normal medium containing inorganic ions and, if necessary, other organic trace components can be used.

【0015】炭素源としては、グルコース、フラクトー
ス、でんぷんおよびセルロースの加水分解物、糖蜜など
の糖類、フマール酸、クエン酸、コハク酸のごとき有機
酸、メタノール、エタノール、グリセロールのごときア
ルコール類などを1〜15%、窒素源として、酢酸アン
モニウムのごとき有機アンモニウム塩、硫酸アンモニウ
ム、塩化アンモニウム、リン酸アンモニウム、硝酸アン
モニウム、のごとき無機アンモニウム塩、アンモニアガ
ス、アンモニア水、尿素等を0.1〜4.0%、有機微
量成分としては、ビオチン等の被要求性物質が0.00
0001%〜0.1%、また必要に応じて、コーンステ
ィープリカー、ペプトン、酵母エキス等0〜5%をそれ
ぞれ適当に含有する培地が好ましく用いられる。これら
の他に、リン酸カリウム、硫酸マグネシウム、塩化カル
シウム、塩化ナトリウム、硫酸亜鉛、硫酸銅、硫酸第1
鉄、等が微量成分として添加されるのが好ましい。また
好ましくは消泡剤なども添加し、培養条件の安定化をは
かる。
Examples of the carbon source include glucose, fructose, hydrolysates of starch and cellulose, sugars such as molasses, organic acids such as fumaric acid, citric acid and succinic acid, and alcohols such as methanol, ethanol and glycerol. 0.1 to 4.0% of an organic ammonium salt such as ammonium acetate, an inorganic ammonium salt such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium nitrate, ammonia gas, aqueous ammonia, urea, etc. as a nitrogen source. As the organic trace component, the required substance such as biotin is 0.00%.
A medium containing 0001% to 0.1%, and optionally 0 to 5% as needed, such as corn steep liquor, peptone, yeast extract, etc., is preferably used. In addition to these, potassium phosphate, magnesium sulfate, calcium chloride, sodium chloride, zinc sulfate, copper sulfate,
Preferably, iron, etc., is added as a minor component. Preferably, an antifoaming agent is also added to stabilize the culture conditions.

【0016】培養は通常、好気条件で行う。培養の間、
培地のpHを3〜8に、温度は20〜40℃に調節し、
24〜144時間振とうまたは通気撹拌培養すれば好ま
しい結果が得られる。
The culture is usually performed under aerobic conditions. During the culture,
The pH of the medium is adjusted to 3-8, the temperature is adjusted to 20-40 ° C,
Preferable results can be obtained by shaking or aeration and stirring culture for 24 to 144 hours.

【0017】[0017]

【実施例】以下、実施例により本発明を具体的に説明す
る。
The present invention will be described below in detail with reference to examples.

【0018】参考例1 (シキミ酸分泌変異株の分離)シトロバクター・フロイ
ンディOFPR36−158の菌体を常法によりN−メ
チル−N’−ニトロ−N−ニトロソグアニジン処理(30
0μg/ml)、30℃10分)した後、この細胞を適当に
希釈し、表1に示した培地に塗布し、30℃で2日間培
養した。表1に示した培地に生育してきた変異処理した
シトロバクター・フロインディOFPR36-158のコロニー
を、常法により表2および表3に示した培地(平板培
地)にレプリカし、30℃で3日間培養した。表2の培
地では生育せず表3の培地で生育したコロニー(4AA-12
株(FERM BP-6722))を単離した。
Reference Example 1 (Isolation of Shikimate Secreting Mutant) The cells of Citrobacter freundii OFPR36-158 were treated with N-methyl-N'-nitro-N-nitrosoguanidine by a conventional method (30).
After 0 μg / ml) and 30 ° C. for 10 minutes, the cells were appropriately diluted, applied to the medium shown in Table 1, and cultured at 30 ° C. for 2 days. Mutant-treated Citrobacter Freundi OFPR36-158 colonies grown on the medium shown in Table 1 were replicated in the usual manner to the medium (plate medium) shown in Tables 2 and 3 and were incubated at 30 ° C. for 3 days. Cultured. Colonies (4AA-12) that did not grow on the medium of Table 2 but grew on the medium of Table 3
Strain (FERM BP-6722) was isolated.

【0019】[0019]

【表1】 [Table 1]

【0020】[0020]

【表2】 [Table 2]

【0021】[0021]

【表3】 参考例2(p-ヒドロキシ安息香酸アナログ耐性変異株の
分離) シトロバクター・フロインディ4AA-12(FERM BP-6722)
の菌体を常法によりN−メチル−N’−ニトロ−N−ニ
トロソグアニジン処理(300μg /ml)、30℃10
分)した後、この細胞を適当に希釈し、表2に示した培
地に4-ヒドロキシ-3-メトキシ安息香酸を10mMの濃度に
加えた平板培地に塗布し、30℃で4日間培養した。
[Table 3] Reference Example 2 (Isolation of mutant resistant to p-hydroxybenzoic acid analog) Citrobacter Freundi 4AA-12 (FERM BP-6722)
Were treated with N-methyl-N'-nitro-N-nitrosoguanidine (300 μg / ml) at 30 ° C.
After that, the cells were appropriately diluted, applied to a plate medium in which 4-hydroxy-3-methoxybenzoic acid was added to the medium shown in Table 2 at a concentration of 10 mM, and cultured at 30 ° C. for 4 days.

【0022】生育してきた変異処理したシトロバクター
・フロインディ4AA-12の変異株のコロニーを、表2に示
した培地で純化し、得られたコロニーを単離しシキミ酸
生産候補株とした。
The grown mutant colonies of the mutant strain of Citrobacter fruindi 4AA-12 which had been subjected to mutation treatment were purified using the medium shown in Table 2, and the obtained colonies were isolated to obtain shikimic acid production candidate strains.

【0023】実施例1(発酵法によるp-ヒドロキシ安息
香酸アナログ耐性変異株の培養およびシキミ酸の生産) 表5に示す菌株をそれぞれ、表1に示した培地(表2の
培地から寒天を除いた液体培地)で30℃24時間振と
うして前培養した後、あらかじめ115℃10分上記滅
菌した表4に示した組成の培地50mlを含む500ml溶
三角フラスコに植え継ぎ、180rpm 、振幅30cmの条
件下で100時間培養した。
Example 1 (Culture of mutant strain resistant to p-hydroxybenzoic acid analog and production of shikimic acid by fermentation method) The strains shown in Table 5 were respectively subjected to the medium shown in Table 1 (agar was removed from the medium shown in Table 2). After shaking for 24 hours at 30 ° C. in a liquid medium, the culture was preliminarily cultured at 115 ° C. for 10 minutes in a 500-ml Erlenmeyer flask containing 50 ml of the medium having the composition shown in Table 4 and sterilized at 180 rpm at an amplitude of 30 cm. The cells were cultured under the conditions for 100 hours.

【0024】培養終了後、菌体、炭酸カルシウムを除去
したろ液中のシキミ酸濃度を用いたHPLC法(カラム:島
津SCR-101H、移動相:0.1Mリン酸 1 mL/min.、検出:2
54 nm)で定量したところ、表5に示すような結果を得
た。
After the cultivation, an HPLC method using the shikimic acid concentration in the filtrate from which the cells and calcium carbonate were removed (column: Shimadzu SCR-101H, mobile phase: 0.1 M phosphoric acid 1 mL / min., Detection: Two
54 nm), the results shown in Table 5 were obtained.

【0025】[0025]

【表4】 [Table 4]

【0026】[0026]

【表5】 参考例3 (4-ヒドロキシ-3-メトキシ安息香酸耐性変
異株の4-ヒドロキシ-3-メトキシ安息香酸に対する耐性
度) 表3に示した培地に表6に示した濃度のp-ヒドロキシ安
息香酸を含ませた培地に表6に示した菌株を塗布し、3
0℃で4日間培養した。その結果を表6に示す。p-ヒド
ロキシ安息香酸アナログ耐性変異株U-5はp-ヒドロキシ
安息香酸アナログである4-ヒドロキシ-3-メトキシ安息
香酸に耐性を獲得していることが示された。
[Table 5] Reference Example 3 (resistance of 4-hydroxy-3-methoxybenzoic acid-resistant mutant to 4-hydroxy-3-methoxybenzoic acid) p-hydroxybenzoic acid at the concentration shown in Table 6 was added to the medium shown in Table 3. The strains shown in Table 6 were applied to the medium so
The cells were cultured at 0 ° C. for 4 days. Table 6 shows the results. It was shown that the p-hydroxybenzoic acid analog resistant mutant U-5 has acquired resistance to the p-hydroxybenzoic acid analog, 4-hydroxy-3-methoxybenzoic acid.

【0027】[0027]

【表6】 実施例2 実施例1での培養液1リットル分の上清をカチオン交換
樹脂リバチットS100(ロームアンドハース社製)に通液
し、その素通り画分を集め、さらにアニオン交換樹脂ダ
イヤイオンWA30(三菱化学(株)製)に通液し、0.1N N
aOHで脱着し、シキミ酸を含有する画分を集め、再びリ
バチットS100に通液し、その素通り画分を120mLに濃縮
した。その液をトリドデシルアミン0.3Mを含むn-ヘプタ
ノール100mLで3回シキミ酸を抽出し、その後オレイン
酸を0.15Mになるように添加して水相へ逆抽出した。そ
の水溶液を活性炭処理後、濃縮晶析し、さらにイソプロ
パノールで再結晶し、純度97.5%以上のシキミ酸結晶2.
9gを得た。
[Table 6] Example 2 A supernatant of 1 liter of the culture solution obtained in Example 1 was passed through a cation exchange resin Livatit S100 (manufactured by Rohm and Haas Co.), the flow-through fraction was collected, and the anion exchange resin Diaion WA30 (Mitsubishi) 0.1 NN
The fraction was desorbed with aOH, and the fraction containing shikimic acid was collected, passed again through Livatit S100, and the flow-through fraction was concentrated to 120 mL. The solution was extracted three times with 100 mL of n-heptanol containing 0.3 M of tridodecylamine and then back-extracted into an aqueous phase by adding oleic acid to 0.15 M. The aqueous solution was treated with activated carbon, concentrated and crystallized, and further recrystallized with isopropanol to obtain a shikimic acid crystal having a purity of 97.5% or more.
9 g were obtained.

【0028】[0028]

【発明の効果】本発明の方法により、既存の方法と比較
し、より経済的なシキミ酸の生産が可能となる。
According to the method of the present invention, shikimic acid can be produced more economically as compared with the existing method.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】シキミ酸を菌体外に分泌する性質を有し、
かつp-ヒドロキシ安息香酸アナログに耐性な性質を持つ
微生物を用いたシキミ酸の製造方法。
(1) It has the property of secreting shikimic acid outside the cells,
A method for producing shikimic acid using a microorganism having a property resistant to a p-hydroxybenzoic acid analog.
【請求項2】シキミ酸を菌体外に分泌する性質を有し、
かつp-ヒドロキシ安息香酸アナログに耐性な性質を持つ
微生物を培養して培養液中にシキミ酸を蓄積せしめ、該
培養液からシキミ酸を単離採取することを特徴とする、
シキミ酸の製造方法。
2. It has the property of secreting shikimic acid outside the cells,
And culturing a microorganism having a property resistant to p-hydroxybenzoic acid analog to accumulate shikimic acid in the culture solution, isolating and collecting shikimic acid from the culture solution,
A method for producing shikimic acid.
【請求項3】微生物がシトロバクター属に属することを
特徴とする請求項1または2記載のシキミ酸の製造方
法。
3. The method for producing shikimic acid according to claim 1, wherein the microorganism belongs to the genus Citrobacter.
【請求項4】シトロバクター属に属する微生物がシトロ
バクター・フロインディであることを特徴とする請求項
3記載のシキミ酸の製造方法。
4. The method for producing shikimic acid according to claim 3, wherein the microorganism belonging to the genus Citrobacter is Citrobacter freundii.
【請求項5】p-ヒドロキシ安息香酸アナログが4-ヒドロ
キシ-3-メトキシ安息香酸であることを特徴とする請求
項1から4のいずれか1項記載のシキミ酸の製造方法
5. The method for producing shikimic acid according to claim 1, wherein the p-hydroxybenzoic acid analog is 4-hydroxy-3-methoxybenzoic acid.
JP2001089091A 2001-03-27 2001-03-27 Method for producing shikimic acid Pending JP2002281993A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001089091A JP2002281993A (en) 2001-03-27 2001-03-27 Method for producing shikimic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001089091A JP2002281993A (en) 2001-03-27 2001-03-27 Method for producing shikimic acid

Publications (1)

Publication Number Publication Date
JP2002281993A true JP2002281993A (en) 2002-10-02

Family

ID=18944075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001089091A Pending JP2002281993A (en) 2001-03-27 2001-03-27 Method for producing shikimic acid

Country Status (1)

Country Link
JP (1) JP2002281993A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013035473A1 (en) 2011-09-07 2013-03-14 国立大学法人信州大学 Method for producing useful metabolite from filamentous fungus
CN109053793A (en) * 2018-08-27 2018-12-21 浙江大学宁波理工学院 The method that photocatalysis removing N- alkyl prepares penem-like pharmaceutical intermediate 4-AA
US10208313B2 (en) 2014-08-21 2019-02-19 Research Institute Of Innovative Technology For The Earth Coryneform bacterium transformant and process for producing organic compound using the same
WO2020040017A1 (en) * 2018-08-23 2020-02-27 住友ベークライト株式会社 Medicinal product, anticancer agent, medicinal intermediate product, and method for producing cyclic carboxylic acid compound or derivative thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013035473A1 (en) 2011-09-07 2013-03-14 国立大学法人信州大学 Method for producing useful metabolite from filamentous fungus
CN103930556A (en) * 2011-09-07 2014-07-16 国立大学法人信州大学 Method for producing useful metabolite from filamentous fungus
CN103930556B (en) * 2011-09-07 2016-03-30 国立大学法人信州大学 From the method for thread fungus production desirable metabolites
US9834796B2 (en) 2011-09-07 2017-12-05 Shinshu University Method for producing useful metabolite from filamentous fungus
US10208313B2 (en) 2014-08-21 2019-02-19 Research Institute Of Innovative Technology For The Earth Coryneform bacterium transformant and process for producing organic compound using the same
WO2020040017A1 (en) * 2018-08-23 2020-02-27 住友ベークライト株式会社 Medicinal product, anticancer agent, medicinal intermediate product, and method for producing cyclic carboxylic acid compound or derivative thereof
CN112601529A (en) * 2018-08-23 2021-04-02 住友电木株式会社 Pharmaceutical, anticancer agent, pharmaceutical intermediate, and process for producing cyclic carboxylic acid compound or derivative thereof
CN109053793A (en) * 2018-08-27 2018-12-21 浙江大学宁波理工学院 The method that photocatalysis removing N- alkyl prepares penem-like pharmaceutical intermediate 4-AA
CN109053793B (en) * 2018-08-27 2020-11-10 浙江大学宁波理工学院 Method for preparing penem drug intermediate 4-AA by removing N-alkyl through photocatalysis

Similar Documents

Publication Publication Date Title
JP3036930B2 (en) Production method of L-isoleucine by fermentation method
JP3006926B2 (en) Method for producing L-threonine by fermentation method
JP3698758B2 (en) Method for producing L-leucine by fermentation
JPH05304969A (en) Production of amino acid by fermentation method
JPH03232497A (en) Production of l-glutamine by fermentation
US5916782A (en) Process for producing aspartase and process for producing L-aspartic acid
JP2002281993A (en) Method for producing shikimic acid
DE3247703C2 (en) Process for the production of L-threonine
EP0502525A1 (en) Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide and R-(-)-2,2-dimethylcyclopropanecarboxylic acid
US3458400A (en) Process for producing l-alanine
JP2000078967A (en) Microorganism belonging to citrobacter and production of shikimic acid
JPH1042860A (en) Production of inositol and acquirement of hexachlorocyclohexane-resistant strain
KR20050026531A (en) Process for producing theanine
JPH0838188A (en) Production of inositol and method for taking glucose metabolism antagonistic substance-resistant strain
WO2000001800A1 (en) Microorganism belonging to the genus citrobacter and process for producing shikimic acid
JPH1042883A (en) Production of inositol and collection of strain resistant to 6-halogeno-6-deoxyglucose
JP2000300249A (en) Microorganism secreting shikimic acid to outside of microbial cell and production of shikimic acid
JP2000041689A (en) Production of inositol
JPH08258A (en) Microorganism belonging to genus candida and production of inositol with the same
JPH03236786A (en) Production of l-threonine by fermentation method
JPH0889262A (en) Production of inositol and preparation of antibiotic resistant strain
JPH1042882A (en) Production of inositol and collection of strain having resistant to cetyltrimethylammonium salt
JPH0378999B2 (en)
JP2004113002A (en) Method for producing glutamic acid using strain having lowered proton atpase activity
JPH04248988A (en) Production of l-proline by fermentation method